The clinical trials on this list are studying Hydroxychloroquine. NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. Plaquenil brand Plaquenil for hallux limitus Interaction hydroxychloroquine sulfate & wellbutrin Is plaquenil a anti-inflammatory Binimetinib and Hydroxychloroquine in Treating Patients With KRAS Mutant Metastatic Pancreatic Cancer The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Huntsman Cancer Institute, University of Utah Photo National Cancer Institute Investigators at the Huntsman Cancer Institute at the University of Utah are conducting a Phase I clinical trial to study the side effects and best dose of hydroxychloroquine when given together with trametinib MEKINIST ®, Novartis in treating patients with pancreatic cancer that has spread to nearby tissue, lymph nodes, or other places in the body and cannot be removed by surgery. The primary goal of the research study is to determine whether treating pancreatic cancer patients with hydroxychloroquine in combination with gemcitabine before surgery is safe. The secondary goal is to determine if this new treatment regimen can effectively treat pancreatic cancer. Talk to your doctor for help in deciding if one is right for you. You may want to think about taking part in a clinical trial. Hydroxychloroquine pancreatic cancer New therapeutic approach for patients with pancreatic cancer, Phase I Study of Trametinib and Hydroxychloroquine in Treating Patients. Chloroquine treats ovaleHydroxychloroquine sulfate brand name Adding Hydroxychloroquine to Chemo Fails to Improve OS in Pancreatic Cancer In a recent study of patients with metastatic pancreatic cancer, hydroxychloroquine added to chemotherapy did not lead to an improvement in overall survival OS; JAMA Oncol. 2019 May 23. Epub ahead of print. Adding Hydroxychloroquine to Chemo Fails to Improve OS in.. Study of Pre-surgery Gemcitabine + Hydroxychloroquine GcHc in Stage.. Binimetinib and Hydroxychloroquine in Treating Patients.. We evaluated hydoxychloroquine HCQ, an inhibitor of autophagy, in patients with pancreatic cancer and analyzed pharmacodynamic markers in treated patients and mice. METHODS Patients with previously treated metastatic pancreatic cancer were administered HCQ at 400 mg n = 10 or 600 mg n = 10 twice daily. Pancreatic carcinoma is found among people who take Hydroxychloroquine sulfate, especially for people who are male, 50-59 old, have been taking the drug for 6 - 12 months, also take medication Methotrexate, Hydroxychloroquine in Previously Treated Patients With Metastatic Pancreatic Cancer The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U. S. Federal Government.